This Apple-like Innovator is Revolutionizing Healthcare

AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.

Click here to learn more about the booming eHealth industry

Raymond Stevens Biography and Net Worth

Director of Danaher

Professor Stevens has served as Provost Professor of Biological Sciences and Chemistry, and Director of The Bridge Institute, at the University of Southern California, a private research university, since July 2014, and as Chief Executive Officer of ShouTi, a biotechnology company, since May 2019. From 1999 until July 2014, he served as Professor of Molecular Biology and Chemistry with The Scripps Research Institute, a non-profit research organization. Professor Stevens is also Founding Director of the iHuman Institute at ShanghaiTech University, and has launched multiple biotechnology companies focused on drug discovery.

Professor Stevens is considered among the world’s most influential biomedical scientists in molecular research. A pioneer in human cellular behavior research, he has been involved in the creation of therapeutic molecules that led to breakthrough drugs aimed at curing influenza, childhood diseases, neuromuscular disorders and diabetes. Professor Stevens’ insights in the area of molecular research, as well as his experience bringing industry and academia together to advance drug development, are highly beneficial to Danaher given our strategic focus on the development of research tools used to understand the causes of disease, identify new therapies and test new drugs and vaccines. His extensive experience living and working in China is also valuable to Danaher given China’s strategic significance to our business.

What is Raymond C. Stevens' net worth?: The estimated net worth of Raymond C. Stevens is at least $2.10 million as of January 25th, 2023. Dr. Stevens owns 8,394 shares of Danaher stock worth more than $2,101,942 as of April 25th. This net worth estimate does not reflect any other assets that Dr. Stevens may own. Learn More about Raymond C. Stevens' net worth.
How do I contact Raymond C. Stevens?: The corporate mailing address for Dr. Stevens and other Danaher executives is 2200 PENNSYLVANIA AVE. N.W SUITE 800W, WASHINGTON DC, 20037. Danaher can also be reached via phone at (202) 828-0850 and via email at [email protected]. Learn More on Raymond C. Stevens' contact information.
Has Raymond C. Stevens been buying or selling shares of Danaher?: Raymond C. Stevens has not been actively trading shares of Danaher in the last ninety days. Most recently, Raymond C. Stevens sold 8,410 shares of the business's stock in a transaction on Wednesday, January 25th. The shares were sold at an average price of $264.27, for a transaction totalling $2,222,510.70. Following the completion of the sale, the director now directly owns 8,394 shares of the company's stock, valued at $2,218,282.38. Learn More on Raymond C. Stevens' trading history.
Who are Danaher's active insiders?: Danaher's insider roster includes Rainer Blair (EVP), Daniel Comas (EVP), Georgeann Couchara (SVP), William Daniel (EVP), Brian Ellis (SVP), Linda Filler (Director), Jose-Carlos Gutierrez-Ramos (SVP), Linda Hefner (Director), Jennifer Honeycutt (EVP), Thomas Joyce, Jr. (CEO), William King (SVP), Angela Lalor (SVP), Angela Lalor (SVP), Teri List (Director), Walter Lohr (Director), Robert Lutz (CAO), Matthew McGrew (CFO), Mitchell Rales (Chairman), Daniel Raskas (SVP), John Schwieters (Director), Alan Spoon (Director), Raymond Stevens (Director), Joakim Weidemanis (EVP), and Elias Zerhouni (Director). Learn More on Danaher's active insiders.
Are insiders buying or selling shares of Danaher?: In the last twelve months, insiders at the conglomerate sold shares 14 times. They sold a total of 115,345 shares worth more than $28,921,815.03. The most recent insider tranaction occured on February, 26th when SVP Daniel Raskas sold 23,757 shares worth more than $5,986,764.00. Insiders at Danaher own 11.1% of the company. Learn More about insider trades at Danaher.
Information on this page was last updated on 2/26/2024.

Raymond C. Stevens Insider Trading History at Danaher

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
1/25/2023	Sell	8,410	$264.27	$2,222,510.70	8,394

Raymond C. Stevens Buying and Selling Activity at Danaher

Danaher Company Overview

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.

Today's Range

Now: $246.73

$245.28

$250.64

50 Day Range

MA: $249.00

$235.37

$256.19

2 Week Range

Now: $246.73

$182.09

$259.00

Volume

1,195,033 shs

Average Volume

2,764,397 shs

Market Capitalization

$182.71 billion

P/E Ratio

41.82

Dividend Yield

0.43%

Beta

0.83